Kolon Life Science Inc

XKRX:102940 (Korea (the Republic of))  
â‚© 19080.00 (-3.59%) Sep 20
At Loss
P/B:
1.84
Market Cap:
â‚© 235.28B ($ 176.57M)
Enterprise V:
â‚© 334.82B ($ 251.27M)
Volume:
27.07K
Avg Vol (2M):
23.51K
Trade In:
Volume:
27.07K
At Loss
Avg Vol (2M):
23.51K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Kolon Life Science Inc ( XKRX:102940 ) from 2009 to Sep 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Kolon Life Science stock (XKRX:102940) PE ratio as of Sep 21 2024 is 0. More Details

Kolon Life Science Inc (XKRX:102940) PE Ratio (TTM) Chart

To

Kolon Life Science Inc (XKRX:102940) PE Ratio (TTM) Historical Data

Total 1274
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Kolon Life Science PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-21 At Loss 2024-07-16 At Loss
2024-09-20 At Loss 2024-07-15 At Loss
2024-09-19 At Loss 2024-07-12 At Loss
2024-09-13 At Loss 2024-07-11 At Loss
2024-09-12 At Loss 2024-07-10 At Loss
2024-09-11 At Loss 2024-07-09 At Loss
2024-09-10 At Loss 2024-07-08 At Loss
2024-09-09 At Loss 2024-07-05 At Loss
2024-09-06 At Loss 2024-07-04 At Loss
2024-09-05 At Loss 2024-07-03 At Loss
2024-09-04 At Loss 2024-07-02 At Loss
2024-09-03 At Loss 2024-07-01 At Loss
2024-09-02 At Loss 2024-06-28 At Loss
2024-08-30 At Loss 2024-06-27 At Loss
2024-08-29 At Loss 2024-06-26 At Loss
2024-08-28 At Loss 2024-06-25 At Loss
2024-08-27 At Loss 2024-06-24 At Loss
2024-08-26 At Loss 2024-06-21 At Loss
2024-08-23 At Loss 2024-06-20 At Loss
2024-08-22 At Loss 2024-06-19 At Loss
2024-08-21 At Loss 2024-06-18 At Loss
2024-08-20 At Loss 2024-06-17 At Loss
2024-08-19 At Loss 2024-06-14 At Loss
2024-08-16 At Loss 2024-06-13 At Loss
2024-08-14 At Loss 2024-06-12 At Loss
2024-08-13 At Loss 2024-06-11 At Loss
2024-08-12 At Loss 2024-06-10 At Loss
2024-08-09 At Loss 2024-06-07 At Loss
2024-08-08 At Loss 2024-06-05 At Loss
2024-08-07 At Loss 2024-06-04 At Loss
2024-08-06 At Loss 2024-06-03 At Loss
2024-08-05 At Loss 2024-05-31 At Loss
2024-08-02 At Loss 2024-05-30 At Loss
2024-08-01 At Loss 2024-05-29 At Loss
2024-07-31 At Loss 2024-05-28 At Loss
2024-07-30 At Loss 2024-05-27 At Loss
2024-07-29 At Loss 2024-05-24 At Loss
2024-07-26 At Loss 2024-05-23 At Loss
2024-07-25 At Loss 2024-05-22 At Loss
2024-07-24 At Loss 2024-05-21 At Loss
2024-07-23 At Loss 2024-05-20 At Loss
2024-07-22 At Loss 2024-05-17 At Loss
2024-07-19 At Loss 2024-05-16 At Loss
2024-07-18 At Loss 2024-05-14 At Loss
2024-07-17 At Loss 2024-05-13 At Loss

Kolon Life Science Inc (XKRX:102940) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Kolon Life Science Inc develops, manufactures and sells Biopharmaceuticals, Active pharmaceutical ingredients, Antimicrobials and Water solutions. Its products include Invossa, KLS-1010, KLS-2020, Azilsartan, Besfloc etc. The company has manufacturing facilities in Chungju, Eumsung and Kimchun.